Bliss GVS Pharma fundamental analysis
BLISSGVS
164.42
7.67 (-4.46%)Last updated on 19 Jan, 2026 | 14:44 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Bliss GVS Pharma Fundamentals
P/E Ratio
16.61
P/B Ratio
1.61
Div. Yield
0.29
Sector P/E
69.39
Sector P/B
0.98
Sec. Div. Yield
0.57
Bliss GVS Pharma Fundamentals is currently trading with a P/E Ratio of 16.61, compared to the sector average of 69.39. Its P/B Ratio stands at 1.61, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0.29%, which is than the sector’s 0.57%.
Bliss GVS Pharma Score Card
Price
Expensive
Growth
Moderate
Quality
Good
Management
Average
On its scorecard, Bliss GVS Pharma reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
